Repligen Corp

Ownership Transactions Reported by 16 Insiders

Symbol
RGEN on Nasdaq
Location
41 Seyon Street, Building 1, Suite 100, Waltham, MA

Insiders trading volume in the past year

Repligen Corp executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Karen A. Dawes Director $14.5M -$193K -1.32% Jun 14, 2024
Jon Snodgres Chief Financial Officer $5.5M May 16, 2023
Anthony Hunt Director $5.14M -$13M -71.7% Dec 5, 2024
Christine Gebski SVP, Filtration & Chromatography $4.48M May 14, 2024
Olivier Loeillot Chief Executive Officer, Director $4.02M Nov 20, 2024
James Bylund Chief Operating Officer $3.77M -$866K -18.7% Apr 2, 2024
Ralf Kuriyel Senior VP, R&D $1.95M -$2.56M -56.7% Aug 2, 2024
Glenn P. Muir Director $1.17M Nov 19, 2024
Jason K. Garland Cfo $947K Nov 20, 2024
Nicolas Barthelemy Director $586K +$151K +34.6% Jun 14, 2024
Martin D. Madaus Director $580K +$202K +53.3% Jun 14, 2024
Manner Carrie Eglinton Director $571K May 16, 2024
Rohin Mhatre Director $498K May 16, 2024
Konstantin Konstantinov Director $314K May 16, 2024
Thomas F. Ryan Jr Director $214K Mar 1, 2022
Margaret Pax Director $130K May 16, 2024

Recent Insider Transactions by Companies or Individuals for Repligen Corp

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.